Free Trial
Stan Berenshteyn

Stan Berenshteyn Analyst Performance

Equity Research Analyst, Digital Health at Wells Fargo & Company

Stan Berenshteyn is a stock analyst at Wells Fargo & Company, covering 9 publicly traded companies across a range of sectors. Over the past year, Stan Berenshteyn has issued 15 stock ratings, including buy and hold recommendations. While full access to Stan Berenshteyn's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Stan Berenshteyn's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ratings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
19 Last 3 Years
Buy Recommendations
55.56% 10 Buy Ratings
Companies Covered
9 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy55.6%10 ratings
Hold44.4%8 ratings
Sell0.0%0 ratings

Out of 18 total stock ratings issued by Stan Berenshteyn at Wells Fargo & Company, the majority (55.6%) have been Buy recommendations, followed by 44.4% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
66.7% of companies on NASDAQ
6 companies
NYSE
33.3% of companies on NYSE
3 companies

Stan Berenshteyn, an analyst at Wells Fargo & Company, currently covers 9 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
8 companies
88.9%
Business Services
1 company
11.1%

Stan Berenshteyn of Wells Fargo & Company specializes in stock coverage within the Medical sector, with additional focus on Business Services companies.

Coverage Industries

IndustryPercentage
MEDICAL INFO SYS
4 companies
44.4%
MEDICAL SERVICES
3 companies
33.3%
CUSTOM COMPUTER PROGRAMMING SERVICES
1 company
11.1%
BUSINESS SERVICES, NOT ELSEWHERE CLASSIFIED
1 company
11.1%

Stan Berenshteyn's Ratings History at Wells Fargo & Company

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Veeva Systems Inc. stock logo
VEEV
Veeva Systems
8/26/2025Boost Price Target$285.54$326.00Overweight
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
8/11/2025Lower Price Target$2.57$6.00Overweight
American Well Corporation stock logo
AMWL
American Well
8/7/2025Lower Price Target$7.50$12.00Overweight
Doximity, Inc. stock logo
DOCS
Doximity
8/4/2025Boost Price Target$58.54$62.00Equal Weight
Omnicell, Inc. stock logo
OMCL
Omnicell
7/21/2025Boost Price Target$27.82$40.00Overweight
Veeva Systems Inc. stock logo
VEEV
Veeva Systems
5/29/2025Boost Price Target$281.19$300.00Overweight
Omnicell, Inc. stock logo
OMCL
Omnicell
5/14/2025Upgrade$28.00$35.00Overweight
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
5/8/2025Lower Price Target$6.90$8.00Equal Weight
Omnicell, Inc. stock logo
OMCL
Omnicell
5/7/2025Lower Price Target$25.42$31.00Equal Weight
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
4/29/2025Lower Price Target$4.60$7.00Overweight
Omnicell, Inc. stock logo
OMCL
Omnicell
4/17/2025Lower Price Target$30.17$38.00Equal Weight
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
2/28/2025Lower Price Target$4.85$8.00Overweight
HealthEquity, Inc. stock logo
HQY
HealthEquity
2/26/2025Boost Price Target$107.45$125.00Overweight
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
1/21/2025Lower Price Target$5.88$10.00Overweight
Omnicell, Inc. stock logo
OMCL
Omnicell
1/13/2025Lower Price Target$42.25$40.00Equal Weight